Navigation Links
Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease
Date:12/1/2011

SAN DIEGO, Dec. 1, 2011 /PRNewswire/ -- Ceregene, Inc. reported today that it has completed enrollment in its Phase 2b trial of CERE-120, a gene therapy product expressing the neurturin (NRTN) gene for the treatment of Parkinson's disease.  This Phase 2b study enrolled 51 patients at 11 medical centers throughout the United States.  CERE-120 is comprised of an AAV vector intended to provide constant, sustained expression of neurturin (NRTN), a neurotrophic factor shown to rescue dying dopaminergic neurons, restoring their function and protecting them from cell death.

Ceregene also reported that it has been chosen to present its work on CERE-120 at Windhover's annual Therapeutic Area Partnership conference as one of the "Top 10 Neuroscience Projects to Watch".  Raymond T. Bartus, Ph.D., Ceregene's executive vice president and chief scientific officer will present at the Boston conference on Thursday December 1st at 1:30 pm.

"Safely completing enrollment in our current Phase 2b CERE-120 Parkinson's study is an important milestone in Ceregene's history, as this study builds on the results of an earlier Phase 2 trial and is powered to demonstrate statistical significance of clinical benefit for CERE-120," stated Jeffrey M. Ostrove, Ph.D., Ceregene's president and chief executive officer.  "We have been fortunate to work with many of the world's leading Parkinson's disease experts in both the clinical trial design and implementation," noted Dr. Ostrove.

"The protocol and dosing scheme developed for the current study leveraged the unique and important insight we gained from the results of our previous clinical studies with CERE-120," noted Dr. Bartus. "Among other things, we observed a fundamental deficiency in the degenerating neurons of Parkinson's disease, which limits how effectively material, like NRTN, is transported from the terminals of these neurons to their cell bodies.  This provided the key insight required
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinsons Disease
2. Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinsons Disease
3. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
4. ETCs Aircrew Training Systems Completes Factory Acceptance Tests for Highly Advanced Suite of Training Equipment for the Republic of Korea Air Force Aeromedical Center
5. Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital
6. Par Pharmaceutical Completes Acquisition of Anchen
7. Mylan Successfully Upsizes and Completes Refinancing of Credit Facility
8. New Spot Vision Screener Completes School Screening in Less Than Two Hours
9. MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation
10. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
11. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- Milliman, Inc., a premier global consulting and actuarial firm, ... Index (MMI), which measures the healthcare costs for a ... an employer-sponsored preferred provider organization (PPO) plan. The cost ... $22,030. "For the second consecutive year, ... basis was the lowest in the history of the ...
(Date:5/22/2013)... , 22. Mai 2013 Kepner-Tregoe ... Beratung, gab heute bekannt, dass der Veteran ... , zum Hauptgeschäftsführer ernannt wurde. Geraghty,s ... Industriebereich wo er zahlreiche Führungspositionen bei Fertigungsunternehmen ... Baxter an, der als Kepner-Tregoe Hauptgeschäftsführer gedient ...
(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues.  STEPh Reports are written by ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), ... associated with inflammation, today announced it will hold a ... investigation and remediation plans relating to vial problems in ... 14, 2010Time: , 5:00 pm Eastern TimeDomestic Dial-in: , ...
... 9, 2010 HeartWare International, Inc. (Nasdaq: ... offer, subject to market and other conditions, $100 million ... "notes") pursuant to an effective shelf registration statement filed ... also intends to grant the underwriters an option to ...
Cached Medicine Technology:Anthera Announces Update Call Regarding Vial Problems 2HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock 2HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock 3
(Date:5/22/2013)... 2013 Textile Exchange, a non-profit ... textile industry, today released the 2011-12 Farm & ... cotton production dropped 8% from last year. This ... 37% drop in 2010-11. Half of the organic ... report, Textile Exchange’s seventh, provides unique data, trends ...
(Date:5/22/2013)... 22, 2013 On May 16, 2012, ... on average, a funeral concierge can help families negotiate lower ... Funeral Financials announces their top 3 reasons ... income in the U.S. having dropped 7.3 percent from ... the average funeral costs 12.6% of an average U.S. households ...
(Date:5/22/2013)... The Yoga of Lady Niguma was created by a ... This is the oldest yoga found in written form (in ... the partner of renowned Indian master and yogi Naropa, and the ... a female yoga master. , Lady Niguma taught the practice ... through a long lineage to the second Dalai Lama, Gendun Gyatso. ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Dr. Andrew ... to painful scalpel surgery with the Laser Assisted New Attachment ... is raising awareness about the connections between gum disease and ... concerns in the United States today, and is linked to ... of bacteria found in the infected gum pockets. , ...
(Date:5/22/2013)... MD (PRWEB) May 22, 2013 On a ... Lisa, spent a few hours watching “The Bourne Legacy” at ... While this may seem like a typical activity to many ... This little stretch of respite from their everyday reality has ... Seals Serving DC | MD | VA. , Life changed ...
Breaking Medicine News(10 mins):Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 2Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 3Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 4Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 3Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Military Family Finds Respite with Easter Seals 2Health News:Military Family Finds Respite with Easter Seals 3
... as HIV and Hepatitis C decades back, will now get ... inquiry is soon to be launched into the contracting of ... transfusions, in what is acknowledged as the biggest treatment blunder ... , The incident took place in the late 70s ...
... study has revealed for the first time that rice bran ... research was conducted by biomedical scientists at the Department of ... has not been tested on humans, but research in the ... has been published in the British Journal of Cancer. ...
... of the “triple negative” type are destructive and lethal, and ... a novel// study Published in the May 1, 2007 issue ... tumors occur commonly among women who are African American and ... lower socioeconomic status (SES). The study also showed that triple ...
... cells to regenerate healthy human liver tissue in a ... the liver, some patients are unable to undergo surgery, ... liver to support the body. ,Researchers at ... cells to help quickly regenerate healthy liver tissue, enabling ...
... technology has found that the most potent cholesterol-lowering ... in the blood vessels that can lead to ... thickened carotid arteries compared to a placebo,” said ... of endocrinology at Wake Forest University School of ...
... southern Indian state of Karnataka is examining a proposal to ... test before marriage. ,State Health Minister R. ... government had written a letter to the federal government suggesting ... were several instances in which unsuspecting women had married HIV+ ...
Cached Medicine News:Health News:Inquiry into Past NHS Treatment Disaster 2Health News:'Triple Negative' Breast Cancers Seem to Affect the Young, Minority 2Health News:Stem Cells to Treat Liver Cancer 2Health News:Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis 2
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
... accommodates up to 12 large slab gels, ... the PROTEAN IEF system, for high-throughput 2-D ... Plus Dodeca cell's cooling and recirculating capabilities, ... high-resolution results. The handcasting system includes the ...
Medicine Products: